Group 6 Copy 49
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Why do wolverines need snow?

    A warming climate in the Arctic is having profound impacts on species that rely on snow and ice, like the polar...

    How do we keep wild rhino populations growing during a poaching crisis? The final countdown

    African rhinos are of great economic and ecological importance within their range states,but are threatened...

    A noninvasive approach to monitor the health of Maine's black bear population

    For over 40 years, state biologists have guided black bear management in Maine using data collected from radio...

    Backer Badge Funded

    A biology project funded by 47 people